Dr Reddys Laboratories (RDY) EBT Margin Growth (1y) (2010 - 2021)
Dr Reddys Laboratories (RDY) EBT Margin Growth (1y) (2010 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -1,585.00 |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | -27.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | -356.00 |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 436.00 |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | -629.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 208.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Alkermes | 8.14 Bn | 7.48 Bn | 397.90 Mn | -2,721.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 442.00 |
| Mar 31, 2021 | -488.00 |
| Sep 30, 2020 | -2,386.00 |
| Jun 30, 2020 | 169.00 |
| Mar 31, 2020 | -209.00 |
| Sep 30, 2019 | -189.00 |
| Jun 30, 2019 | 63.00 |
| Mar 31, 2019 | 861.00 |
| Dec 31, 2018 | 397.00 |
| Sep 30, 2018 | -82.00 |
| Dec 31, 2017 | 220.00 |
| Sep 30, 2017 | -328.00 |
| Dec 31, 2016 | -695.00 |
| Sep 30, 2016 | -169.00 |
| Dec 31, 2015 | -21.00 |
| Sep 30, 2015 | -175.00 |
| Dec 31, 2014 | -697.00 |
| Sep 30, 2014 | -207.00 |
| Mar 31, 2014 | 2,023.00 |
| Dec 31, 2013 | -90.00 |